UNSPSC 51131520: Plerixafor

This classification denotes a chemokine receptor antagonist and antiviral agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S915P5499N. European Medicines Agency schedules Plerixafor in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB28849. Plerixafor generally arises in the molecular formula C28H54N8.

UNSPSC 51131520 Plerixafor is a Commodity code that appears in state and local procurement records with minimal relevance to actual buying activity. Plerixafor is a pharmaceutical agent used in stem cell mobilization for collection in hematopoietic stem cell transplantation; however, the single recent state and local opportunity tagged under this code — Sourcewell's RFP #061626, posted May 12, 2026, with response due June 16, 2026 — solicits law enforcement equipment on behalf of its Participating Entities, a scope that bears no connection to pharmaceutical procurement or medical devices.

The code shows no documented state and local contracting activity aligned with its pharmaceutical scope. The mismatch between the code assignment and the actual solicitation content suggests either a data-entry error in the tagging system or that this Commodity code is not in active use for state and local health-system, hospital, or clinical procurement. Firms pursuing pharmaceutical or medical-device contracting with state agencies, counties, health districts, or hospital systems should verify coding alignment in actual RFPs and IFBs rather than rely on this code as a procurement signal.